How to Buy iolcp Shares on Fincept?
You can buy IOL Chemicals and Pharmaceuticals Limited shares on Different Brokers & Banks by creating an account and completing KYC verification online.
NSE: IOL Chemicals and Pharmaceuticals Limited Share Price Today, Share Analysis, Latest Updates & Insights | Fincept
Stay informed with the latest announcements for Iolcp, including updates on board meetings and corporate actions.
IOL Chemicals and Pharmaceuticals Limited - https://www.iolcp.com
IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company offers active pharmaceutical ingredients (API), such as ibuprofen lysinate and ibuprofen sodium; and other APIs, including metformin, fenofibrate, lamotrigine, clopidogrel bisulphate, pantoprazole, gabapentin, levetiracetam, paracetamol, etc. Its active pharmaceutical ingredients are used for the treatment of anti-inflammatory, analgesic and antipyretic, anti-diabetic, anti- platelet, anti-cholesterol, anti- convulsant, and anti-cholelithic, as well as proton pump inhibitor. IOL Chemicals and Pharmaceuticals Limited provides specialty industrial chemicals comprising ethyl acetate, iso butyl benzene, acetyl chloride, para amino phenol, and mono chloro acetic acid to food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and chemical intermediates industries. IOL Chemicals and Pharmaceuticals Limited was incorporated in 1986 and is based in Ludhiana, India.
IOL Chemicals and Pharmaceuticals Limited Share Price Today
363.00
OPEN
368.00
HIGH
356.35
LOW
358.70
CLOSE
184 K
VOLUME
2,444 Cr
Market Cap
403376
Average Volume
Healthcare
Sector
NSI
Exchange
IOL Chemicals and Pharmaceuticals Limited Share Analysis & 2025 Insights
Investor Presentations
| Date | Description | Download |
|---|
SIP
Lumpsum
Invested Amount: ₹
Estimated Returns: ₹
Total Value: ₹
NSE: IOLCP Stock Actions
Company |
Symbol |
ISIN |
Subject |
Ex Date |
Face Value |
Broadcast Date |
|---|---|---|---|---|---|---|
IOL Chemicals and Pharmaceuticals Limited |
IOLCP |
INE485C01011 |
Annual General Meeting |
16 Aug 2024 |
10 |
N/A |
IOL Chemicals and Pharmaceuticals Limited |
IOLCP |
INE485C01011 |
Interim Dividend - Rs 5 Per Share |
16 Feb 2024 |
10 |
N/A |
IOL Chemicals and Pharmaceuticals Limited |
IOLCP |
INE485C01011 |
Annual General Meeting |
03 Aug 2023 |
10 |
N/A |
IOL Chemicals and Pharmaceuticals Limited |
IOLCP |
INE485C01011 |
Interim Dividend - Rs 4 Per Share |
17 Feb 2023 |
10 |
N/A |
IOL Chemicals and Pharmaceuticals Limited |
IOLCP |
INE485C01011 |
Annual General Meeting |
18 Aug 2022 |
10 |
N/A |
NSE: IOLCP Recent Announcements
Symbol |
Date |
Description |
Industry |
|---|---|---|---|
IOLCP |
02 Jan 2025, 11:58:02 |
Copy of Newspaper Publication |
Pharmaceuticals |
IOLCP |
01 Jan 2025, 18:32:20 |
Shareholders meeting |
Pharmaceuticals |
IOLCP |
27 Dec 2024, 19:08:04 |
Updates |
Pharmaceuticals |
IOLCP |
27 Dec 2024, 18:44:35 |
Stock split |
Pharmaceuticals |
IOLCP |
26 Dec 2024, 18:33:35 |
Trading Window-XBRL |
Pharmaceuticals |
NSE: IOLCP Corporate Governance
Name |
Symbol |
Timestamp |
Submission Date |
XBRL Document |
|---|---|---|---|---|
IOL Chemicals and Pharmaceuticals Limited |
IOLCP |
03 Jan 2025, 16:22:00 |
03 Jan 2025, 16:22:00 |
|
IOL Chemicals and Pharmaceuticals Limited |
IOLCP |
04 Jan 2025, 07:03:00 |
04 Jan 2025, 07:04:00 |
|
IOL Chemicals and Pharmaceuticals Limited |
IOLCP |
11 Oct 2024, 11:42:00 |
11 Oct 2024, 11:42:00 |
|
IOL Chemicals and Pharmaceuticals Limited |
IOLCP |
12 Jul 2024, 17:27:00 |
12 Jul 2024, 17:27:00 |
|
IOL Chemicals and Pharmaceuticals Limited |
IOLCP |
28 May 2024, 15:03:00 |
28 May 2024, 15:03:00 |
NSE: IOLCP Detailed Governance
Category |
Date of Birth |
Date of Initial Appointment |
DIN |
Director Name |
Status |
|---|---|---|---|---|---|
Independent Director,Chairperson & Non-Executive Director |
15 May 1953 |
06 Feb 2019 |
00136657 |
Rajender Mohan Malla |
Active |
Executive Director-MD |
06 Dec 1962 |
13 Nov 1986 |
00044068 |
Varinder Gupta |
Active |
Executive Director |
13 Feb 1992 |
29 May 2015 |
07198109 |
Vikas Gupta |
Active |
Executive Director |
04 Jan 1995 |
03 Apr 2023 |
08204917 |
Abhiraj Gupta |
Active |
Executive Director |
15 Sep 1969 |
04 Jun 2021 |
09189020 |
Kushal Kumar Rana |
Active |
NSE: IOLCP Board Meetings
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
|---|---|---|---|---|---|
Board Meeting Intimation |
IOLCP |
N/A |
INE485C01011 |
IOL Chemicals and Pharmaceuticals Limited |
05 Nov 2024, 17:40:34 |
Financial Results |
IOLCP |
N/A |
INE485C01011 |
IOL Chemicals and Pharmaceuticals Limited |
30 Jul 2024, 18:19:26 |
IOL CHEMICALS AND PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 14-May-2024 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2024 . |
IOLCP |
N/A |
INE485C01011 |
IOL Chemicals and Pharmaceuticals Limited |
06 May 2024, 18:02:56 |
IOL CHEMICALS AND PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 06-Feb-2024 to consider and approve the Quarterly Audited Financial results of the Company for the period ended December 2023 and Dividend. |
IOLCP |
N/A |
INE485C01011 |
IOL Chemicals and Pharmaceuticals Limited |
29 Jan 2024, 18:09:03 |
IOL CHEMICALS AND PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 08-Nov-2023 to inter-alia consider and approve the Audited Financial results of the Company for the Half Yearly ended September 2023 . |
IOLCP |
N/A |
INE485C01011 |
IOL Chemicals and Pharmaceuticals Limited |
30 Oct 2023, 15:43:15 |
NSE: IOLCP Event Calendar
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
Description |
|---|---|---|---|---|---|---|
Stock Split |
IOLCP |
- |
INE485C01011 |
IOL Chemicals and Pharmaceuticals Limited |
18 Dec 2024, 00:00:00 |
To consider stock split of equity shares |
Financial Results |
IOLCP |
- |
INE485C01011 |
IOL Chemicals and Pharmaceuticals Limited |
05 Nov 2024, 00:00:00 |
To consider and approve the financial results for the period ended September 30, 2024 |
Financial Results |
IOLCP |
- |
INE485C01011 |
IOL Chemicals and Pharmaceuticals Limited |
30 Jul 2024, 00:00:00 |
To consider and approve the financial results for the period ended Jun 30, 2024 |
Financial Results |
IOLCP |
- |
INE485C01011 |
IOL Chemicals and Pharmaceuticals Limited |
06 May 2024, 00:00:00 |
To consider and approve the financial results for the period ended March 31, 2024 |
Financial Results/Dividend |
IOLCP |
- |
INE485C01011 |
IOL Chemicals and Pharmaceuticals Limited |
29 Jan 2024, 00:00:00 |
To consider and approve the financial results for the period ended December 31, 2023 and dividend |
NSE: IOLCP Balance Sheet Data In (Cr)
| date | period_type | Ordinary Shares Number | Share Issued | Net Debt | Total Debt | Tangible Book Value | Invested Capital | Working Capital | Net Tangible Assets | Capital Lease Obligations | Common Stock Equity | Total Capitalization | Total Equity Gross Minority Interest | Stockholders Equity | Other Equity Interest | Retained Earnings | Additional Paid In Capital | Capital Stock | Common Stock | Total Liabilities Net Minority Interest | Total Non Current Liabilities Net Minority Interest | Other Non Current Liabilities | Non Current Pension And Other Postretirement Benefit Plans | Non Current Deferred Revenue | Non Current Deferred Taxes Liabilities | Long Term Debt And Capital Lease Obligation | Long Term Capital Lease Obligation | Long Term Debt | Long Term Provisions | Current Liabilities | Other Current Liabilities | Current Deferred Taxes Liabilities | Current Debt And Capital Lease Obligation | Current Capital Lease Obligation | Current Debt | Pensionand Other Post Retirement Benefit Plans Current | Current Provisions | Payables | Other Payable | Dividends Payable | Total Tax Payable | Accounts Payable | Total Assets | Total Non Current Assets | Other Non Current Assets | Non Current Prepaid Assets | Investmentin Financial Assets | Available For Sale Securities | Goodwill And Other Intangible Assets | Other Intangible Assets | Net PPE | Accumulated Depreciation | Gross PPE | Construction In Progress | Other Properties | Machinery Furniture Equipment | Buildings And Improvements | Land And Improvements | Properties | Current Assets | Other Current Assets | Hedging Assets Current | Assets Held For Sale Current | Restricted Cash | Prepaid Assets | Inventory | Finished Goods | Work In Process | Raw Materials | Other Receivables | Taxes Receivable | Accounts Receivable | Allowance For Doubtful Accounts Receivable | Gross Accounts Receivable | Cash Cash Equivalents And Short Term Investments | Other Short Term Investments | Cash And Cash Equivalents | Cash Equivalents | Cash Financial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30T00:00:00 | quarterly | 58,705,502.00 | 58,705,502.00 | 1,100,400,000.00 | 1,284,200,000.00 | 16,463,300,000.00 | 17,877,000,000.00 | 5,559,400,000.00 | 16,463,300,000.00 | 0.00 | 16,592,800,000.00 | 16,592,800,000.00 | 16,592,800,000.00 | 16,592,800,000.00 | 16,005,700,000.00 | 0.00 | 0.00 | 587,100,000.00 | 587,100,000.00 | 6,058,200,000.00 | 760,800,000.00 | 0.00 | 0.00 | 0.00 | 686,900,000.00 | 0.00 | 0.00 | 0.00 | 73,900,000.00 | 5,297,400,000.00 | 113,300,000.00 | 0.00 | 1,284,200,000.00 | 0.00 | 1,284,200,000.00 | 0.00 | 37,400,000.00 | 3,381,700,000.00 | 0.00 | 0.00 | 0.00 | 3,381,700,000.00 | 22,651,000,000.00 | 11,794,200,000.00 | 209,300,000.00 | 0.00 | 250,700,000.00 | 250,700,000.00 | 129,500,000.00 | 129,500,000.00 | 11,204,700,000.00 | 0.00 | 11,204,700,000.00 | 1,217,600,000.00 | 9,987,100,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10,856,800,000.00 | 765,300,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3,756,800,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 95,900,000.00 | 4,645,600,000.00 | 0.00 | 0.00 | 1,593,200,000.00 | 1,409,400,000.00 | 183,800,000.00 | 0.00 | 0.00 |
| 2024-03-31T00:00:00 | quarterly | 58,705,502.00 | 58,705,502.00 | 250,700,000.00 | 327,600,000.00 | 15,987,600,000.00 | 16,442,700,000.00 | 5,597,700,000.00 | 15,987,600,000.00 | 0.00 | 16,115,100,000.00 | 16,115,100,000.00 | 16,115,100,000.00 | 16,115,100,000.00 | 15,528,000,000.00 | 13,244,800,000.00 | 2,257,200,000.00 | 587,100,000.00 | 587,100,000.00 | 6,328,900,000.00 | 728,900,000.00 | 400,000.00 | 67,100,000.00 | 0.00 | 661,400,000.00 | 0.00 | 0.00 | 0.00 | 67,100,000.00 | 5,600,000,000.00 | 235,800,000.00 | 0.00 | 327,600,000.00 | 0.00 | 327,600,000.00 | 33,900,000.00 | 33,900,000.00 | 4,914,200,000.00 | 211,200,000.00 | 11,200,000.00 | 0.00 | 4,691,800,000.00 | 22,444,000,000.00 | 11,246,300,000.00 | 243,500,000.00 | 242,100,000.00 | 465,100,000.00 | 465,100,000.00 | 127,500,000.00 | 127,500,000.00 | 10,213,900,000.00 | -3,010,300,000.00 | 13,224,200,000.00 | 998,300,000.00 | 6,700,000.00 | 9,320,300,000.00 | 1,486,500,000.00 | 1,412,400,000.00 | 0.00 | 11,197,700,000.00 | -5,900,000.00 | 6,000,000.00 | 0.00 | 307,200,000.00 | 584,000,000.00 | 4,248,400,000.00 | 1,649,500,000.00 | 448,500,000.00 | 2,150,400,000.00 | 118,600,000.00 | 67,600,000.00 | 4,712,300,000.00 | -16,500,000.00 | 4,728,800,000.00 | 1,159,500,000.00 | 1,082,600,000.00 | 76,900,000.00 | 0.00 | 76,900,000.00 |
| 2024-03-31T00:00:00 | annual | 58,705,502.00 | 58,705,502.00 | 250,700,000.00 | 327,600,000.00 | 15,987,600,000.00 | 16,442,700,000.00 | 5,597,700,000.00 | 15,987,600,000.00 | 0.00 | 16,115,100,000.00 | 16,115,100,000.00 | 16,115,100,000.00 | 16,115,100,000.00 | 15,528,000,000.00 | 13,244,800,000.00 | 2,257,200,000.00 | 587,100,000.00 | 587,100,000.00 | 6,328,900,000.00 | 728,900,000.00 | 400,000.00 | 67,100,000.00 | 0.00 | 661,400,000.00 | 0.00 | 0.00 | 0.00 | 67,100,000.00 | 5,600,000,000.00 | 235,800,000.00 | 0.00 | 327,600,000.00 | 0.00 | 327,600,000.00 | 33,900,000.00 | 33,900,000.00 | 4,914,200,000.00 | 211,200,000.00 | 11,200,000.00 | 0.00 | 4,691,800,000.00 | 22,444,000,000.00 | 11,246,300,000.00 | 243,500,000.00 | 242,100,000.00 | 465,100,000.00 | 465,100,000.00 | 127,500,000.00 | 127,500,000.00 | 10,213,900,000.00 | -3,010,300,000.00 | 13,224,200,000.00 | 998,300,000.00 | 6,700,000.00 | 9,320,300,000.00 | 1,486,500,000.00 | 1,412,400,000.00 | 0.00 | 11,197,700,000.00 | -5,900,000.00 | 6,000,000.00 | 0.00 | 307,200,000.00 | 584,000,000.00 | 4,248,400,000.00 | 1,649,500,000.00 | 448,500,000.00 | 2,150,400,000.00 | 118,600,000.00 | 67,600,000.00 | 4,712,300,000.00 | -16,500,000.00 | 4,728,800,000.00 | 1,159,500,000.00 | 1,082,600,000.00 | 76,900,000.00 | 0.00 | 76,900,000.00 |
| 2023-09-30T00:00:00 | quarterly | 58,705,502.00 | 58,705,502.00 | 558,200,000.00 | 590,500,000.00 | 15,785,600,000.00 | 16,487,900,000.00 | 4,892,000,000.00 | 15,785,600,000.00 | 0.00 | 15,897,400,000.00 | 15,897,400,000.00 | 15,897,400,000.00 | 15,897,400,000.00 | 15,310,300,000.00 | 0.00 | 0.00 | 587,100,000.00 | 587,100,000.00 | 4,916,700,000.00 | 615,300,000.00 | 800,000.00 | 0.00 | 0.00 | 587,000,000.00 | 0.00 | 0.00 | 0.00 | 27,500,000.00 | 4,301,400,000.00 | 163,600,000.00 | 0.00 | 590,500,000.00 | 0.00 | 590,500,000.00 | 0.00 | 91,100,000.00 | 3,144,100,000.00 | 0.00 | 0.00 | 0.00 | 3,144,100,000.00 | 20,814,100,000.00 | 11,620,700,000.00 | 293,900,000.00 | 0.00 | 2,377,200,000.00 | 2,377,200,000.00 | 111,800,000.00 | 111,800,000.00 | 8,837,800,000.00 | 0.00 | 8,837,800,000.00 | 397,900,000.00 | 8,439,900,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9,193,400,000.00 | 300,400,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3,162,700,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 71,100,000.00 | 4,901,100,000.00 | 0.00 | 0.00 | 758,100,000.00 | 725,800,000.00 | 32,300,000.00 | 0.00 | 0.00 |
| 2023-03-31T00:00:00 | quarterly | 58,705,502.00 | 58,705,502.00 | 782,400,000.00 | 798,100,000.00 | 14,986,800,000.00 | 15,873,500,000.00 | 4,641,300,000.00 | 14,986,800,000.00 | 1,800,000.00 | 15,077,200,000.00 | 15,077,200,000.00 | 15,077,200,000.00 | 15,077,200,000.00 | 14,490,100,000.00 | 12,194,000,000.00 | 2,257,200,000.00 | 587,100,000.00 | 587,100,000.00 | 5,144,100,000.00 | 581,500,000.00 | 1,400,000.00 | 16,500,000.00 | 0.00 | 563,600,000.00 | 0.00 | 0.00 | 0.00 | 16,500,000.00 | 4,562,600,000.00 | 170,400,000.00 | 0.00 | 798,100,000.00 | 1,800,000.00 | 796,300,000.00 | 81,300,000.00 | 81,300,000.00 | 3,438,400,000.00 | 287,200,000.00 | 9,000,000.00 | 0.00 | 3,142,200,000.00 | 20,221,300,000.00 | 11,017,400,000.00 | 90,100,000.00 | 97,300,000.00 | 2,040,700,000.00 | 2,040,700,000.00 | 90,400,000.00 | 90,400,000.00 | 8,325,600,000.00 | -2,424,700,000.00 | 10,750,300,000.00 | 814,000,000.00 | 15,000,000.00 | 7,848,000,000.00 | 1,368,900,000.00 | 704,400,000.00 | 0.00 | 9,203,900,000.00 | 410,700,000.00 | 2,500,000.00 | 0.00 | 57,500,000.00 | 410,700,000.00 | 3,255,200,000.00 | 1,097,000,000.00 | 618,500,000.00 | 1,539,700,000.00 | 221,300,000.00 | 17,500,000.00 | 5,052,800,000.00 | -14,100,000.00 | 5,066,900,000.00 | 186,400,000.00 | 172,500,000.00 | 13,900,000.00 | 0.00 | 13,900,000.00 |
| 2023-03-31T00:00:00 | annual | 58,705,502.00 | 58,705,502.00 | 782,400,000.00 | 798,100,000.00 | 14,986,800,000.00 | 15,873,500,000.00 | 4,641,300,000.00 | 14,986,800,000.00 | 1,800,000.00 | 15,077,200,000.00 | 15,077,200,000.00 | 15,077,200,000.00 | 15,077,200,000.00 | 14,490,100,000.00 | 12,194,000,000.00 | 2,257,200,000.00 | 587,100,000.00 | 587,100,000.00 | 5,144,100,000.00 | 581,500,000.00 | 1,400,000.00 | 16,500,000.00 | 0.00 | 563,600,000.00 | 0.00 | 0.00 | 0.00 | 16,500,000.00 | 4,562,600,000.00 | 170,400,000.00 | 0.00 | 798,100,000.00 | 1,800,000.00 | 796,300,000.00 | 81,300,000.00 | 81,300,000.00 | 3,438,400,000.00 | 287,200,000.00 | 9,000,000.00 | 0.00 | 3,142,200,000.00 | 20,221,300,000.00 | 11,017,400,000.00 | 90,100,000.00 | 97,300,000.00 | 2,040,700,000.00 | 2,040,700,000.00 | 90,400,000.00 | 90,400,000.00 | 8,325,600,000.00 | -2,424,700,000.00 | 10,750,300,000.00 | 814,000,000.00 | 15,000,000.00 | 7,848,000,000.00 | 1,368,900,000.00 | 704,400,000.00 | 0.00 | 9,203,900,000.00 | 410,700,000.00 | 2,500,000.00 | 0.00 | 57,500,000.00 | 410,700,000.00 | 3,255,200,000.00 | 1,097,000,000.00 | 618,500,000.00 | 1,539,700,000.00 | 221,300,000.00 | 17,500,000.00 | 5,052,800,000.00 | -14,100,000.00 | 5,066,900,000.00 | 186,400,000.00 | 172,500,000.00 | 13,900,000.00 | 0.00 | 13,900,000.00 |
| 2022-03-31T00:00:00 | annual | 58,705,502.00 | 58,705,502.00 | 395,200,000.00 | 439,500,000.00 | 13,889,300,000.00 | 14,352,300,000.00 | 5,674,200,000.00 | 13,889,300,000.00 | 12,000,000.00 | 13,924,800,000.00 | 13,924,800,000.00 | 13,924,800,000.00 | 13,924,800,000.00 | 13,335,700,000.00 | 11,037,600,000.00 | 2,257,200,000.00 | 587,100,000.00 | 587,100,000.00 | 5,698,200,000.00 | 564,200,000.00 | 500,000.00 | 0.00 | 0.00 | 531,800,000.00 | 1,800,000.00 | 1,800,000.00 | 0.00 | 30,100,000.00 | 5,134,000,000.00 | 211,300,000.00 | 0.00 | 437,700,000.00 | 10,200,000.00 | 427,500,000.00 | 73,400,000.00 | 73,400,000.00 | 4,270,900,000.00 | 170,900,000.00 | 7,100,000.00 | 0.00 | 4,092,900,000.00 | 19,623,000,000.00 | 8,814,800,000.00 | 103,000,000.00 | 109,200,000.00 | 1,850,600,000.00 | 1,850,600,000.00 | 35,500,000.00 | 35,500,000.00 | 6,624,900,000.00 | -2,015,200,000.00 | 8,640,100,000.00 | 1,020,300,000.00 | 24,000,000.00 | 6,034,200,000.00 | 1,000,900,000.00 | 560,700,000.00 | 0.00 | 10,808,200,000.00 | 348,800,000.00 | 3,200,000.00 | 5,600,000.00 | 863,800,000.00 | 343,200,000.00 | 4,098,900,000.00 | 927,500,000.00 | 597,000,000.00 | 2,574,400,000.00 | 226,600,000.00 | 9,100,000.00 | 4,698,000,000.00 | -13,900,000.00 | 4,711,900,000.00 | 559,800,000.00 | 527,500,000.00 | 32,300,000.00 | 0.00 | 32,300,000.00 |
| 2021-03-31T00:00:00 | annual | 58,705,502.00 | 58,705,502.00 | 0.00 | 27,300,000.00 | 12,598,200,000.00 | 12,604,300,000.00 | 7,317,400,000.00 | 12,598,200,000.00 | 27,300,000.00 | 12,604,300,000.00 | 12,604,300,000.00 | 12,604,300,000.00 | 12,604,300,000.00 | 12,017,200,000.00 | 9,713,100,000.00 | 2,257,200,000.00 | 587,100,000.00 | 587,100,000.00 | 3,496,600,000.00 | 591,100,000.00 | 3,800,000.00 | 36,800,000.00 | 3,800,000.00 | 532,200,000.00 | 18,300,000.00 | 18,300,000.00 | 0.00 | 36,800,000.00 | 2,905,500,000.00 | 67,400,000.00 | 46,600,000.00 | 9,000,000.00 | 9,000,000.00 | 0.00 | 60,600,000.00 | 60,600,000.00 | 2,677,000,000.00 | 284,300,000.00 | 4,400,000.00 | 46,600,000.00 | 2,388,300,000.00 | 16,100,900,000.00 | 5,878,000,000.00 | 50,400,000.00 | 53,800,000.00 | 196,800,000.00 | 196,800,000.00 | 6,100,000.00 | 6,100,000.00 | 5,604,200,000.00 | -1,642,300,000.00 | 7,246,500,000.00 | 482,700,000.00 | 32,800,000.00 | 5,431,400,000.00 | 876,900,000.00 | 422,700,000.00 | 0.00 | 10,222,900,000.00 | 274,200,000.00 | 0.00 | 0.00 | 293,400,000.00 | 272,000,000.00 | 2,951,500,000.00 | 633,800,000.00 | 357,300,000.00 | 1,960,400,000.00 | 336,700,000.00 | 0.00 | 3,003,100,000.00 | -1,200,000.00 | 3,004,300,000.00 | 3,366,200,000.00 | 3,042,800,000.00 | 323,400,000.00 | 150,300,000.00 | 173,100,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 279,000,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 38,500,000.00 | 5,100,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 13,600,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 18,200,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,026,700,000.00 | 0.00 |
NSE: IOLCP Cash Flow Data In (Cr)
| date | period_type | Free Cash Flow | Repayment Of Debt | Issuance Of Debt | Issuance Of Capital Stock | Capital Expenditure | End Cash Position | Other Cash Adjustment Outside Changein Cash | Beginning Cash Position | Changes In Cash | Financing Cash Flow | Interest Paid Cff | Cash Dividends Paid | Common Stock Dividend Paid | Net Common Stock Issuance | Common Stock Issuance | Net Issuance Payments Of Debt | Net Short Term Debt Issuance | Short Term Debt Payments | Net Long Term Debt Issuance | Long Term Debt Payments | Long Term Debt Issuance | Investing Cash Flow | Net Other Investing Changes | Interest Received Cfi | Net Investment Purchase And Sale | Sale Of Investment | Purchase Of Investment | Net PPE Purchase And Sale | Sale Of PPE | Purchase Of PPE | Capital Expenditure Reported | Operating Cash Flow | Taxes Refund Paid | Change In Working Capital | Change In Payable | Change In Inventory | Change In Receivables | Other Non Cash Items | Depreciation And Amortization | Depreciation | Gain Loss On Investment Securities | Net Foreign Currency Exchange Gain Loss | Gain Loss On Sale Of PPE | Net Income From Continuing Operations |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | 159,100,000.00 | 0.00 | 0.00 | 0.00 | -2,741,700,000.00 | 76,900,000.00 | 0.00 | 13,900,000.00 | 63,000,000.00 | -925,000,000.00 | -161,000,000.00 | -293,500,000.00 | -293,500,000.00 | 0.00 | 0.00 | -468,700,000.00 | -468,700,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1,912,800,000.00 | 900,000.00 | 134,800,000.00 | 674,700,000.00 | 680,100,000.00 | -5,400,000.00 | -2,723,200,000.00 | 18,500,000.00 | -2,741,700,000.00 | 0.00 | 2,900,800,000.00 | -420,200,000.00 | 903,300,000.00 | 1,619,900,000.00 | -993,200,000.00 | 276,600,000.00 | 19,500,000.00 | 629,100,000.00 | 629,100,000.00 | -300,000.00 | -47,700,000.00 | -1,000,000.00 | 1,816,500,000.00 |
| 2023-03-31T00:00:00 | annual | -895,500,000.00 | 0.00 | 0.00 | 0.00 | -2,118,200,000.00 | 13,900,000.00 | 0.00 | 32,300,000.00 | -18,400,000.00 | -41,100,000.00 | -164,000,000.00 | -235,000,000.00 | -235,000,000.00 | 0.00 | 0.00 | 368,800,000.00 | 368,800,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1,200,000,000.00 | -83,600,000.00 | 177,300,000.00 | 802,300,000.00 | 978,400,000.00 | -176,100,000.00 | -2,096,000,000.00 | 22,200,000.00 | -2,118,200,000.00 | 0.00 | 1,222,700,000.00 | -471,000,000.00 | -636,900,000.00 | -1,049,900,000.00 | 843,700,000.00 | -430,700,000.00 | -3,300,000.00 | 461,600,000.00 | 461,600,000.00 | -100,000.00 | -19,700,000.00 | 5,900,000.00 | 1,886,500,000.00 |
| 2022-03-31T00:00:00 | annual | -602,400,000.00 | 0.00 | 427,500,000.00 | 0.00 | -1,532,900,000.00 | 32,300,000.00 | 1,000,000.00 | 323,400,000.00 | -291,100,000.00 | -16,400,000.00 | -81,100,000.00 | -352,200,000.00 | -352,200,000.00 | 0.00 | 0.00 | 427,500,000.00 | 427,500,000.00 | 0.00 | 427,500,000.00 | 0.00 | 427,500,000.00 | -1,205,200,000.00 | -101,300,000.00 | 186,000,000.00 | 224,100,000.00 | 235,500,000.00 | -11,400,000.00 | -1,514,000,000.00 | 18,900,000.00 | -1,532,900,000.00 | 0.00 | 930,500,000.00 | -625,800,000.00 | -1,023,400,000.00 | 1,831,900,000.00 | -1,147,500,000.00 | -1,707,800,000.00 | -99,300,000.00 | 432,600,000.00 | 432,600,000.00 | -200,000.00 | -12,800,000.00 | 10,900,000.00 | 2,248,500,000.00 |
| 2021-03-31T00:00:00 | annual | 2,715,700,000.00 | -559,900,000.00 | 0.00 | 279,500,000.00 | -1,082,100,000.00 | 323,400,000.00 | 0.00 | 280,900,000.00 | 42,500,000.00 | -582,800,000.00 | -57,000,000.00 | -234,800,000.00 | 0.00 | 279,500,000.00 | 279,500,000.00 | -559,900,000.00 | -559,200,000.00 | -559,200,000.00 | -700,000.00 | -700,000.00 | 0.00 | -3,172,500,000.00 | -15,400,000.00 | 129,500,000.00 | -2,212,300,000.00 | 600,000.00 | -2,212,900,000.00 | -1,074,300,000.00 | 7,800,000.00 | -1,082,100,000.00 | 0.00 | 3,797,800,000.00 | -1,422,500,000.00 | -765,100,000.00 | 606,100,000.00 | -1,076,200,000.00 | -295,000,000.00 | -106,500,000.00 | 389,200,000.00 | 389,200,000.00 | -100,000.00 | -12,100,000.00 | 1,000,000.00 | 5,713,900,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | -2,286,000,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -205,700,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | -117,900,000.00 | -2,168,100,000.00 | -2,168,100,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -802,800,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NSE: IOLCP Income Statement Data In (Cr)
| date | period_type | Tax Effect Of Unusual Items | Tax Rate For Calcs | Normalized EBITDA | Total Unusual Items | Total Unusual Items Excluding Goodwill | Net Income From Continuing Operation Net Minority Interest | Reconciled Depreciation | Reconciled Cost Of Revenue | EBITDA | EBIT | Net Interest Income | Interest Expense | Interest Income | Normalized Income | Net Income From Continuing And Discontinued Operation | Total Expenses | Rent Expense Supplemental | Diluted Average Shares | Basic Average Shares | Diluted EPS | Basic EPS | Diluted NI Availto Com Stockholders | Net Income Common Stockholders | Otherunder Preferred Stock Dividend | Net Income | Net Income Including Noncontrolling Interests | Net Income Continuous Operations | Tax Provision | Pretax Income | Other Non Operating Income Expenses | Special Income Charges | Other Special Charges | Write Off | Net Non Operating Interest Income Expense | Total Other Finance Cost | Interest Expense Non Operating | Interest Income Non Operating | Operating Income | Operating Expense | Other Operating Expenses | Depreciation And Amortization In Income Statement | Depreciation Income Statement | Selling General And Administration | Selling And Marketing Expense | General And Administrative Expense | Rent And Landing Fees | Gross Profit | Cost Of Revenue | Total Revenue | Operating Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | 0.08 | 0.00 | 255.11 | 0.29 | 0.29 | 134.43 | 62.91 | 1,423.10 | 255.40 | 192.49 | -2.11 | 10.84 | 13.99 | 134.22 | 134.43 | 1,951.03 | 1.71 | 5.87 | 5.87 | 0.00 | 0.00 | 134.43 | 134.43 | 0.00 | 134.43 | 134.43 | 134.43 | 47.22 | 181.65 | 2.46 | -0.06 | -0.10 | 0.16 | -2.11 | 5.26 | 10.84 | 13.99 | 167.93 | 527.93 | 218.23 | 62.91 | 62.91 | 57.94 | 51.25 | 6.69 | 1.71 | 695.86 | 1,423.10 | 2,118.96 | 2,118.96 |
| 2023-03-31T00:00:00 | annual | -0.09 | 0.00 | 245.86 | -0.36 | -0.36 | 139.14 | 46.16 | 1,576.71 | 245.50 | 199.34 | 0.26 | 10.69 | 16.73 | 139.41 | 139.14 | 2,021.52 | 0.39 | 5.87 | 5.87 | 0.00 | 0.00 | 139.14 | 139.14 | 0.00 | 139.14 | 139.14 | 139.14 | 49.51 | 188.65 | 1.52 | -0.59 | 0.59 | 0.00 | 0.26 | 5.78 | 10.69 | 16.73 | 180.17 | 444.81 | 177.86 | 46.16 | 46.16 | 67.68 | 61.85 | 5.83 | 0.39 | 624.98 | 1,576.71 | 2,201.69 | 2,201.69 |
| 2022-03-31T00:00:00 | annual | -3.77 | 0.00 | 285.38 | -14.84 | -14.84 | 167.67 | 43.26 | 1,596.66 | 270.54 | 227.28 | 9.75 | 2.43 | 18.04 | 178.74 | 167.67 | 1,952.18 | 0.23 | 5.87 | 5.87 | 0.00 | 0.00 | 167.67 | 167.67 | 0.00 | 167.67 | 167.67 | 167.67 | 57.18 | 224.85 | 3.31 | -15.02 | 15.02 | 0.00 | 9.75 | 5.86 | 2.43 | 18.04 | 216.19 | 355.52 | 115.11 | 43.26 | 43.26 | 71.34 | 66.84 | 4.50 | 0.23 | 571.71 | 1,596.66 | 2,168.37 | 2,168.37 |
| 2021-03-31T00:00:00 | annual | -0.02 | 0.00 | 611.34 | -0.09 | -0.09 | 444.56 | 38.92 | 1,124.17 | 611.25 | 572.33 | 10.14 | 0.94 | 15.97 | 444.63 | 444.56 | 1,393.00 | 0.14 | 5.83 | 5.83 | 0.00 | 0.00 | 444.56 | 444.56 | 0.00 | 444.56 | 444.56 | 444.56 | 126.83 | 571.39 | 1.27 | -0.10 | 0.10 | 0.00 | 10.14 | 4.89 | 0.94 | 15.97 | 553.14 | 268.83 | 80.30 | 38.92 | 38.92 | 54.83 | 50.78 | 4.05 | 0.14 | 821.97 | 1,124.17 | 1,946.14 | 1,946.14 |
FII & DII Data (In Cr)
| Date | FII Gross Purchase | FII Gross Sales | FII Net Purchase / Sales | DII Gross Purchase | DII Gross Sales | DII Net Purchase / Sales |
|---|---|---|---|---|---|---|
| 2025-02-03 | 12,505.92 | 16,464.29 | -3,958.37 | 19,319.48 | 16,611.25 | 2,708.23 |
| 2025-01-30 | 10,513.63 | 15,096.58 | -4,582.95 | 13,934.35 | 11,768.46 | 2,165.89 |
| 2025-01-29 | 7,644.40 | 10,230.83 | -2,586.43 | 12,871.38 | 11,078.67 | 1,792.71 |
| 2025-01-27 | 9,488.57 | 14,504.03 | -5,015.46 | 16,503.43 | 9,861.28 | 6,642.15 |
| 2025-01-24 | 11,230.47 | 13,988.96 | -2,758.49 | 12,835.41 | 10,433.10 | 2,402.31 |
| 2025-01-23 | 13,316.55 | 18,779.07 | -5,462.52 | 14,412.73 | 10,700.18 | 3,712.55 |
| 2025-01-22 | 12,936.64 | 16,962.89 | -4,026.25 | 15,437.18 | 11,796.96 | 3,640.22 |
Piotroski F-Score
5/9
0
1
2
3
4
5
6
7
8
9
Key Metrics
EPS
17.03
P/E
24.44216
P/B
1.5163548
Dividend Yield
1.35%
Market Cap
2,443.62 Cr.
Face Value
274.507
Book Value
274.507
ROE
5.72%
EBITDA Growth
209.86 Cr.
Debt/Equity
2.033
Short Term
Subscribe to unlock this feature
Medium Term
Subscribe to unlock this feature
Long Term
Subscribe to unlock this feature
Yearly Stock Performance Heatmap
Latest Updates
Ashoka Buildcon Arm Signs Rs 1,391 Crore Pact With NHAI
Ashoka Buildcon Ltd. announced on Monday, via an exchange filing, that its wholly owned subsidiary, Ashoka Bowaichandi Guskara Road Pvt Ltd., has exec...
Budget 2025: Rahul Bajoria On Addressing Income Growth And Consumption Trends
"However, discretionary, high-value consumption is taking a step back due to income growth settling at high single digits." Over the past fe...
FPIs Stay Net Sellers, Sell Stocks Worth Rs 2,575 Crore
Foreign portfolio investors stayed net sellers for the second straight session on Monday and sold stocks worth approximately Rs 2,575.1 crore, accordi...
Budget 2025: AMFI Seeks Tax Policy Reforms To Drive Mutual Fund Investments In 15-Point Proposal
The Association of Mutual Funds of India on Monday released a 15-point proposal for Union Budget 2025-26 requesting changes in tax policies that are i...
Apple iPhone SE 4: Price To Features, 11 Things You Need To Know
iPhone 16e (Not iPhone SE 4): If recent reports are to be believed, Apple may discontinue the SE label and rename iPhone SE 4 as iPhone 16e. Most Affo...
Rupee Closed Weaker Against The US Dollar
The rupee weakened by five paise to close at 85.83 against the US dollar. The Indian rupee had declined to a fresh low against the US dollar during th...
Table Space Founder Amit Banerji Dies Of Heart Attack At Age Of 45
Amit Banerji, the founder, chairman and chief executive officer of managed workspace provider Table Space, died after suffering from a heart attack, r...
War Fatigue, Economic Breakdown Or Pro-West? Why Syria's Al-Sharaa Is Seen Soft On Israel
The strategic positions have been used by Israeli forces to carry out hundreds of strikes to destroy Syria's military infrastructure. In 2011, be...
Popular Questions
What is the Market Cap of iolcp?
The market capitalization of IOL Chemicals and Pharmaceuticals Limited is ₹2,444 Cr as of 05 Feb 2025.
What are the PE and PB ratios of IOL Chemicals and Pharmaceuticals Limited?
The PE and PB ratios of IOL Chemicals and Pharmaceuticals Limited are Not Available and 1.5163548 respectively as of 05 Feb 2025.
What is the 52 Week High of IOL Chemicals and Pharmaceuticals Limited?
The 52-week high of IOL Chemicals and Pharmaceuticals Limited is ₹537.7 as of 05 Feb 2025.
What is the 52 Week Low of IOL Chemicals and Pharmaceuticals Limited?
The 52-week low of IOL Chemicals and Pharmaceuticals Limited is ₹330.85 as of 05 Feb 2025.
What are the earnings per share (EPS) for IOL Chemicals and Pharmaceuticals Limited?
The Earnings Per Share (EPS) of IOL Chemicals and Pharmaceuticals Limited is ₹17.03 as per the most recent quarterly results available on Fincept.
What is the ROE (Return on Equity) of IOL Chemicals and Pharmaceuticals Limited?
The Return on Equity (ROE) of IOL Chemicals and Pharmaceuticals Limited is 5.72% as per the most recent financial year data. Explore more on Fincept.